Biblio
Export 362 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is E [Clear All Filters]
“Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1035-50, 2016.
, “Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.”, J Alzheimers Dis, vol. 51, no. 1, pp. 165-78, 2016.
, “Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.”, J Alzheimers Dis, vol. 53, no. 1, pp. 303-13, 2016.
, “A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.
, “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
, “Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1395-404, 2016.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
, “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
, “Retinal oximetry imaging in Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 79-83, 2016.
, “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
, “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
, “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.
, “Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 651-60, 2016.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 713-29, 2016.
, “Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
, “Unmet Needs of Community-Dwelling Primary Care Patients with Dementia in Germany: Prevalence and Correlates.”, J Alzheimers Dis, vol. 51, no. 3, pp. 847-55, 2016.
, “Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1321-33, 2016.
, “A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.”, J Alzheimers Dis, vol. 53, no. 3, pp. 981-9, 2016.
, “The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.”, J Alzheimers Dis, vol. 52, no. 2, pp. 581-608, 2016.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
,